Another vaccine may soon be added to America's arsenal in the fight against , as announced it submitted data to the Food and Drug Administration () for its Covid vaccine.The long awaited shot was expected to roll out in 2021 but faced repeated delays over the past year, which the company blames on supply issues.Now, the company has finally prepared data to submit to regulators which shows its two-shot vaccine is 90 percent effective against the virus - though the data was collected before the discovery of the vaccine resistant variant late last year.
Load More
Load More